N
VAXX

Nuveen’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Nuveen’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58,029
Closed -$41.6K – 3467
2024
Q1 		$41.6K Hold
58,029
– – ﹤0.01% 3271
2023
Q4 		$49.3K Hold
58,029
– – ﹤0.01% 3304
2023
Q3 		$79.5K Hold
58,029
– – ﹤0.01% 3142
2023
Q2 		$146K Buy
+58,029
New +$123K ﹤0.01% 3134

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Nuveen's VAXX Position: Q2 2024 in Review

Nuveen sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 58,029 shares — an estimated $41.6K sold.

Nuveen first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $146K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Nuveen reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 58,029 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $41.6K.
  • Nuveen first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
  • Nuveen's Vaxxinity, Inc. Class A Common Stock position peaked at $146K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.